Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

ProQR Therapeutics (PRQR) Equity Ratio (2016 - 2025)

ProQR Therapeutics' Equity Ratio history spans 6 years, with the latest figure at 0.44 for Q4 2025.

  • On a quarterly basis, Equity Ratio fell 16.95% to 0.44 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.44, a 16.95% decrease, with the full-year FY2025 number at 0.44, down 16.95% from a year prior.
  • Equity Ratio hit 0.44 in Q4 2025 for ProQR Therapeutics, down from 0.53 in the prior quarter.
  • Over the last five years, Equity Ratio for PRQR hit a ceiling of 0.73 in Q2 2021 and a floor of 0.0 in Q1 2021.
  • Historically, Equity Ratio has averaged 0.44 across 5 years, with a median of 0.46 in 2025.
  • Biggest five-year swings in Equity Ratio: soared 97626213.75% in 2022 and later crashed 38.82% in 2023.
  • Tracing PRQR's Equity Ratio over 5 years: stood at 0.54 in 2021, then dropped by 28.51% to 0.39 in 2022, then decreased by 22.88% to 0.3 in 2023, then surged by 75.65% to 0.53 in 2024, then decreased by 16.95% to 0.44 in 2025.
  • Business Quant data shows Equity Ratio for PRQR at 0.44 in Q4 2025, 0.53 in Q4 2024, and 0.3 in Q4 2023.